Episode description

Hannah Claridge is the Head of Neurotechnology at TTP which is a consultancy that helps neurotech companies create the next generation of medical devices.

***This podcast is sponsored by Iris Biomedical, check out their Neurotech Startup Services here***

Top 3 Takeaways:

• "I think consulting is really fantastic for the variety that it offers you. Not just in terms of seeing problems, but also working with different types of companies, different types of technologies, and having different day-to-day activities as well"

• "There have been cases where we've worked with very small companies where the company is composed of two or three founders whose sole role is the concept of the idea and the thinking behind what's the business case, and then gathering in the funding and passing that funding through for us to carry out the product development work. Now that's pretty unusual in most cases."

• "You need to be able to balance the efficacy of treatment with the side effects that are usually created. And if you go too far in one direction or the other, then that treatment stops being helpful. So if you stimulate too strongly, and the effect might be really effective but if the side effects are too strong, then patients aren't going to tolerate that."

0:45 Do you want to introduce yourself better than I just did?

1:45 "Let's talk about clinical translation, what does that entail?"

4:45 Iris Biomedical ad sponsorship

5:45 "What's a typical contract length and what does it look like from beginning to end?"

9:00 "It really sounds like you guys do everything. You could just take an idea and then bring it almost all the way to market"

10:15 "Do you wanna share the neurotech projects you've worked on?"

11:15 "What's a common problem that you see?"

17:15 "How does a company recover, like from having so much help to not having any help? Is that typical too?"

19:45 "What does your day-to-day look like? What are you usually doing?"

22:30 What's a typical pathway into the career of consulting?

25:15 "If you had unlimited funding or if a company had unlimited funding, what would you do?"

28:00 "Is there anything that we didn't talk about that you wanted to mention?"